All products / DC8845
AMG337
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $700 USDRequest a quote → |
| 250 mg | $1,300 USDRequest a quote → |
| 1 g | $2,600 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
AMG-337 is a potent and highly selective small molecule ATP-competitive MET kinase inhibitor. AMG 337 inhibits MET kinase activity with an IC50 of < 5nM in enzymatic assays.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC8845 |
|---|---|
| Product name | AMG337 |
| CAS | 1173699-31-4 |
| Molecular formula | C23H22FN7O3 |
| Molecular weight | 463.4643 |
| Purity | >98% |
| SMILES | FC1=C([H])C(C2C([H])=NN(C([H])([H])[H])C=2[H])=C([H])N2C1=NN=C2[C@@]([H])(C([H])([H])[H])N1C([H])=C([H])C2=C(C([H])=C(C([H])=N2)OC([H])([H])C([H])([H])OC([H])([H])[H])C1=O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — AMG337 (DC8845)Source references
[1]. Paul E. Hughes, et al. AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models. Cancer Res October 1, 2014 74; 728 [2]. Cecchi F, et al. Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 Jun;16(6):553-572.
